Table 4.
Curcumin treatment induced differential expressed miRNAs (24 h)
| ProbeSet_Name | Fold_change (B1_vs_A1) | Regulation (B1_vs_A1) | median CV (%) | label |
|---|---|---|---|---|
| hsa-miR-149 | 2.4357 | Up | 5.32 | Cy3 |
| hsa-miR-138 | 2.6614 | Up | 6.12 | Cy3 |
| hsa-miR-181b | 1.8996 | Up | 6.34 | Cy3 |
| hsa-miR-193b | 2.0147 | Up | 6.58 | Cy3 |
| hsa-miR-339-5p | 2.1366 | Up | 7.11 | Cy3 |
| hsa-miR-22 | 1.9654 | Up | 6.04 | Cy3 |
| hsa-miR-671-5p | 1.7452 | Up | 6.23 | Cy3 |
| hsa-miR-124 | 1.8639 | Up | 5.99 | Cy3 |
| hsa-miR-744 | 2.1660 | Up | 6.10 | Cy3 |
| hsa-miR-455-3p | 1.8254 | Up | 6.38 | Cy3 |
| hsa-miR-494 | 1.6332 | Down | 7.46 | Cy3 |
| hsa-miR-186 | 2.4365 | Down | 8.20 | Cy3 |
| hsa-miR-100 | 2.3334 | Down | 6.09 | Cy3 |
| hsa-miR-154 | 1.7562 | Down | 7.13 | Cy3 |
A1: DMSO control group, B1: 20 μM Curcumin group.